Talk about a snippet and taking the wrong message from my post. As it stands the MKT Cap is roughly $400 million with 1.7 B shares outstanding. Pretty much where most expected billion $ revenue biotech companies trade prior to approval. Another poster posted for years the increase in share count daily. Did it change anything? No. The share count kept increasing. All that is authorized is 1.7 Billion. I expect them all to enter the market at sometime. At this time the count matters little unless Linda loses control.
Market Data 
Markets 
AI
